1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Recalls

Another Class I Recall For Medtronic, This Time For Defibrillators

 
• By Shawn M. Schmitt

The US FDA on 12 April affixed its highest risk classification to a recall of certain implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) made by Medtronic. It’s the third class I recall for the medtech giant since 1 March.

Medtronic sign.

A recall by Medtronic PLC of certain implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds) has been designated as high-risk class I by the US Food and Drug Administration.

The recalled defibrillators – sold under the names Amplia, Brava, Claria, Compia, Evera, Visia and Viva – were distributed between August 2012 and May 2018

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Recalls

More from Policy & Regulation